Latest market price
158.20
-1.59-1.00%
TA
Loading chart...
Snapshot
| Index | S&P 500 | P/E | 10.65 | EPS (ttm) | 15.01 | Insider Own | 1.16% | Shs Outstand | 76.85M | Perf Week | 1.89% |
| Market Cap | 12.28B | Forward P/E | 9.75 | EPS next Y | 16.40 | Insider Trans | -36.10% | Shs Float | 76.13M | Perf Month | -3.56% |
| Enterprise Value | 14.77B | PEG | 1.19 | EPS next Q | 3.60 | Short Float | 2.92% | Perf Quarter | -13.11% | ||
| Income | 1.19B | P/S | 1.96 | EPS this Y | 6.41% | Short Ratio | 4.28 | Perf Half Y | 4.68% | ||
| Sales | 6.28B | P/B | 1.99 | EPS next Y | 5.80% | ROA | 0.00% | Short Interest | 2.22M | Perf YTD | 14.25% |
| Book/sh | 80.10 | P/C | 26.99 | EPS next 5Y | 8.96% | ROE | 19.46% | 52W High | 191.55 -17.41% | Perf Year | 20.65% |
| Cash/sh | 5.92 | P/FCF | 11.99 | EPS past 3/5Y | 15.86% 15.57% | ROIC | 0.00% | 52W Low | 127.85 23.74% | Perf 3Y | 40.80% |
| Dividend Est. | 1.32 (0.83%) | EV/EBITDA | 24.78 | Sales past 3/5Y | 4.70% 4.83% | Gross Margin | 21.19% | Volatility | 1.83% 2.08% | Perf 5Y | 72.28% |
| Dividend TTM | 1.26 (0.80%) | EV/Sales | 2.35 | EPS Y/Y TTM | 8.93% | Oper. Margin | 9.14% | ATR (14) | 3.82 | Perf 10Y | 151.72% |
| Dividend Ex-Date | Oct 05, 2026 | Quick Ratio | — | Sales Y/Y TTM | 5.72% | Profit Margin | 18.88% | RSI (14) | 40.01 | Recom | 2.89 |
| Dividend Gr. 3/5Y | 8.61% 7.38% | Current Ratio | — | EPS Q/Q | 0.62% | SMA20 | -2.47% | Beta | 0.45 | Target Price | 174.60 |
| Payout | 5.80% | Debt/Eq | 0.48 | Sales Q/Q | 5.49% | SMA50 | -4.92% | Rel Volume | 1.26 | Prev Close | 159.79 |
| Employees | 3,695 | LT Debt/Eq | 0.43 | Earnings | Feb 03 | SMA200 | 0.00% | Avg Volume | 512.78K | Price | 158.20 |
| IPO Date | Oct 01, 1980 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -1.31% 2.18% | Net Debt/EBITDA | 4.17 | Volume | 648,404 | Change | -1.00% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-26-26 | Reiterated | Wells Fargo | Overweight | $180 |
| Oct-23-26 | Reiterated | UBS | Sell | $165 |
| Oct-23-26 | Downgrade | Piper Sandler | Overweight → Neutral | $200 → $165 |
| Oct-05-26 | Reiterated | Morgan Stanley | Overweight | $181 → $197 |
| Jul-15-26 | Reiterated | Piper Sandler | Overweight | $175 → $200 |
| Jul-10-26 | Reiterated | Jefferies | Hold | $90 → $166 |
| May-26-26 | Reiterated | Piper Sandler | Overweight | $167 → $175 |
| May-21-26 | Reiterated | Morgan Stanley | Overweight | $176 → $181 |
| Apr-24-26 | Reiterated | Truist Securities | Buy | $158 → $185 |
| Feb-18-26 | Reiterated | Evercore ISI Group | In Line | $95 → $157 |
Latest News· Times ET
Oct-30-26
09:00AM
Oct-27-26
Oct-27-2603:25PM
04:13AM
Oct-26-26
Oct-26-2607:20PM
Oct-23-26
Oct-23-2606:16PM
06:03AM
Oct-22-26
04:07PM
What Globe Life (GL) Said on Its Q3 Earnings Callmarketbeat.com
03:29PM
Oct-21-26
Oct-21-2608:00PM
06:51PM
04:10PM
GLOBE LIFE INC. REPORTS THIRD QUARTER 2026 RESULTSprnewswire.com
Company
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6,280 | 5,999 | 5,778 | 5,448 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 4,949 | 3,995 | 3,908 | 3,807 | — | — | — | — | — | |
| Gross Profit | 1,331 | 2,004 | 1,870 | 1,640 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 743 | 198 | 383 | 332 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 14 | 343 | 161 | 114 | — | — | — | — | — | |
| Operating Income | 573 | 1,463 | 1,327 | 1,194 | — | — | — | — | — | |
| Interest Expense | 143 | 141 | 127 | 102 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 1,033 | 118 | 127 | 102 | — | — | — | — | — | |
| Net Income Before Taxes | 1,463 | 1,440 | 1,327 | 1,194 | — | — | — | — | — | |
| Income Taxes | 278 | 279 | 256 | 224 | — | — | — | — | — | |
| Consolidated Net Income | 1,186 | 1,161 | 1,071 | 971 | — | — | — | — | — | |
| Net Income From Continuing Operations | 1,186 | 1,161 | 1,071 | 971 | — | — | — | — | — | |
| Net Income | 1,186 | 1,161 | 1,071 | 971 | — | — | — | — | — | |
| EPS (Recurring) | 15.22 | 14.30 | 11.99 | 10.21 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 15.22 | 14.30 | 11.99 | 10.21 | — | — | — | — | — | |
| EPS (Diluted) | 15.01 | 14.06 | 11.94 | 10.07 | — | — | — | — | — | |
| EBITDA | 596 | 1,592 | 1,454 | 1,297 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 10.54 | 9.95 | 9.34 | 12.09 | — | — | — | — | — | |
| Price To Sales Ratio | 1.96 | 1.89 | 1.62 | 2.12 | — | — | — | — | — | |
| Gross Margin | 21.19 | 33.41 | 32.36 | 30.10 | — | — | — | — | — | |
| Operating Margin | 9.12 | 24.39 | 22.97 | 21.92 | — | — | — | — | — | |
| Net Margin | 18.89 | 19.35 | 18.54 | 17.82 | — | — | — | — | — | |
| Shares Outstanding | 78 | 81 | 84 | 95 | — | — | — | — | — | |
| Market Capitalization | 12,340 | 11,329 | 9,368 | 11,563 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Hensley Robert Edward | EVP & Chief Investment Officer | Mar 02 '26 | Sale | 145.04 | 5,138 | 745,240 | 12,384 | Oct 27 |
| MAJORS MICHAEL CLAY | EVP - Chief Strategy Officer | Oct 23 '26 | Sale | 154.48 | 14,377 | 2,220,900 | 39,141 | Oct 26 |
| Hensley Robert Edward | EVP & Chief Investment Officer | Sep 22 '26 | Sale | 170.07 | 10,000 | 1,700,701 | 12,384 | Sep 23 |
| Hensley Robert Edward | EVP & Chief Investment Officer | Sep 22 '26 | Option Exercise | 103.23 | 10,000 | 1,032,300 | 22,384 | Sep 23 |
| MITCHELL ROBERT BRIAN | EVP, General Counsel and CRO | Aug 07 '26 | Option Exercise | 103.23 | 23,000 | 2,374,290 | 30,981 | Aug 10 |
| MITCHELL ROBERT BRIAN | EVP, General Counsel and CRO | Aug 07 '26 | Sale | 183.34 | 23,000 | 4,216,848 | 7,981 | Aug 10 |
| Darden James Matthew | Co-Chairman & CEO | Jul 31 '26 | Option Exercise | 98.32 | 50,000 | 4,916,000 | 108,451 | Aug 03 |
| Darden James Matthew | Co-Chairman & CEO | Jul 31 '26 | Sale | 182.43 | 50,000 | 9,121,638 | 58,451 | Aug 03 |
| Kalmbach Thomas Peter | EVP & CFO | Jul 30 '26 | Option Exercise | 112.27 | 21,000 | 2,357,690 | 71,568 | Jul 30 |
| Kalmbach Thomas Peter | EVP & CFO | Jul 30 '26 | Sale | 180.06 | 21,000 | 3,781,163 | 50,568 | Jul 30 |
| MAJORS MICHAEL CLAY | EVP - Chief Strategy Officer | Jul 29 '26 | Option Exercise | 103.23 | 37,000 | 3,819,510 | 90,518 | Jul 30 |
| MAJORS MICHAEL CLAY | EVP - Chief Strategy Officer | Jul 29 '26 | Sale | 178.64 | 37,000 | 6,609,526 | 53,518 | Jul 30 |
| Kalmbach Thomas Peter | EVP & CFO | Jul 28 '26 | Sale | 178.58 | 25,650 | 4,580,564 | 50,568 | Jul 29 |
| Kalmbach Thomas Peter | EVP & CFO | Jul 28 '26 | Option Exercise | 124.05 | 25,650 | 3,181,929 | 76,218 | Jul 29 |
| Skarjune Dolores L | EVP and Chief Admin. Officer | Jun 30 '26 | Option Exercise | 103.23 | 1,850 | 190,976 | 15,547 | Jun 30 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.